1. Home
  2. NOMD vs NUVB Comparison

NOMD vs NUVB Comparison

Compare NOMD & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nomad Foods Limited

NOMD

Nomad Foods Limited

HOLD

Current Price

$10.34

Market Cap

1.4B

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.23

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOMD
NUVB
Founded
2014
2018
Country
United Kingdom
United States
Employees
N/A
298
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NOMD
NUVB
Price
$10.34
$4.23
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$12.50
$11.38
AVG Volume (30 Days)
1.5M
4.3M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
7.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$203.82
Revenue Next Year
$1.45
$58.18
P/E Ratio
$8.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.99
$1.57
52 Week High
$18.33
$9.75

Technical Indicators

Market Signals
Indicator
NOMD
NUVB
Relative Strength Index (RSI) 60.33 37.13
Support Level $9.47 $4.07
Resistance Level $10.46 $5.23
Average True Range (ATR) 0.40 0.29
MACD 0.10 -0.06
Stochastic Oscillator 86.89 14.09

Price Performance

Historical Comparison
NOMD
NUVB

About NOMD Nomad Foods Limited

Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: